Home › Funds › PRIMECAP MANAGEMENT CO/CA/ › BSX
PRIMECAP MANAGEMENT CO/CA/ position in BSX
BOSTON SCIENTIFIC CORP · Health Care
PRIMECAP MANAGEMENT CO/CA/ reported holding 58,624,997 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$2.56B, representing 1.59% of its reported portfolio and ranking #12 among its reported holdings. PRIMECAP MANAGEMENT CO/CA/ has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PRIMECAP MANAGEMENT CO/CA/'s BSX position evolved
PRIMECAP MANAGEMENT CO/CA/ first disclosed a stake in BSX in Q3 2023 at 37,355,169 shares (US$1.97B). The position peaked in Q2 2025 at 34,662,722 shares, worth US$3.72B. Across 13 filings, PRIMECAP MANAGEMENT CO/CA/ increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 58,624,997 shares valued at US$2.56B — an increase of 8,104,083 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2026 (shares rose 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 37.36M | $1.97B | New |
| Q4 2023 | 37.91M | $2.19B | Add |
| Q1 2024 | 37.95M | $2.60B | Hold |
| Q2 2024 | 37.96M | $2.92B | Hold |
| Q3 2024 | 37.83M | $3.17B | Hold |
| Q4 2024 | 36.93M | $3.30B | Reduce |
| Q1 2025 | 36.50M | $3.68B | Reduce |
| Q2 2025 | 34.66M | $3.72B | Reduce |
| Q3 2025 | 33.10M | $3.23B | Reduce |
| Q4 2025 | 31.10M | $2.97B | Reduce |
| Q1 2026 | 32.53M | $2.04B | Add |
| Q2 2026 | 50.52M | $2.16B | Add |
| Q3 2026 | 58.62M | $2.56B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 17 other funds we track also report a position in BSX — the largest reported positions include MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B), Janus Henderson Group (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on PRIMECAP MANAGEMENT CO/CA/
FAQ
How long has PRIMECAP MANAGEMENT CO/CA/ held BSX?
PRIMECAP MANAGEMENT CO/CA/ has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PRIMECAP MANAGEMENT CO/CA/'s current position in BSX?
As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 58.62M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $2.56B, representing 1.59% of its reported portfolio and ranking #12.
Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling BSX?
In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ increased its position in BSX. The position peaked in Q2 2025 at 34.66M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include MFS Investment Management, D. E. Shaw & Co, Janus Henderson Group, among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.